Hi Dutchfella, 

Feb 19,  you must have a premonition, as Zenith just did a small PP, did get some??

Below is part of what you stated

Despite the $5 MM milestone payment, ZEN, like all Junior biotechs, wil be interested in adding to their cash reserves to cover expenses because science is expensive. I would not be surprised to see another financing not too far down the road. Will they wait for some good news to boost the offering price above the last US$2 sale or will they do the sale pre news to give more US$2 shares to "hint hint nudge nudge wink wink" family, friends, partners and past big investors?

I think i will contact them and ask to be put on their investor list for the next financing --- just in case. "Say no more, say no more!"